Projects and Grants per year
Personal profile
Research Interests
- Ovarian Cancer Screening.
- Chemotherapy Induced Cognitive Impairment.
- Developmental therapeutics in gynecologic cancer.
- Implementation of Precision Medicine.
Education/Academic qualification
Residency, Dartmouth College
2006
Doctor of Medicine, University Of Kentucky
2003
Bachelor of Science, University Of Kentucky
1998
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Rachel Miller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
GOG-3091: A Two-Arm Randomized, Double-Blind, Placebo-Controlled Phase 2 Selection Trial to Evaluate the Efficacy and Safety of VB10.16 Alone or in Combination with Atezolizumab in Patients with HPV16-Positive, PD-L1-positive, Recurrent or Metastatic Cerv
Miller, R. (PI)
Gynecological Oncology Group Foundation Incorporated
5/14/24 → 5/14/26
Project: Research project
-
GOG-3068-HOTT: A Phase III Randomized Trial of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) with Cisplatin Versus no HIPEC at the Time of Interval Cytoreductive Surgery Followed by Niraparib Maintenance in Patients with Newly Diagnosed Stage III and
Miller, R. (PI) & Dietrich, C. (Former PI)
Gynecological Oncology Group Foundation Incorporated
12/6/23 → 12/6/26
Project: Research project
-
IMGN853-0421/GOG-3078: Randomized, Multicenter, Open-label, Phase 3 study of Mirvetuximab Soravtansine in Combination with Bevacizumab Versus Bevacizumab Alone as Maintenance Therapy for Patients with FRa-positive Recurrent Platinum-sensitive Epithelial o
Miller, R. (PI)
8/30/23 → 8/30/26
Project: Research project
-
A Phase 3, Randomized, Double-Blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-Paclitaxel Versus Placebo Plus Carboplatin-Paclitaxel in Patients with Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Miller, R. (PI)
Gynecological Oncology Group Foundation Incorporated
11/15/19 → 1/16/27
Project: Research project
-
Member Institution Purchased Service Agreement
Miller, R. (PI) & Romond, E. (Former PI)
NRG Oncology Foundation Incorporated
3/1/14 → 2/28/27
Project: Research project
-
A Phase 1 Dose Escalation of Lapatinib and Paclitaxel in Recurrent Ovarian Cancer
Cao, C. D., McCorkle, J. R., Yan, D., Esfahani, H. S., Jayswal, R., Piecoro, D., Li, N., Baldwin, L. A., Miller, R. W., Desimone, C. P., Dietrich, C. S., Ueland, F. R. & Kolesar, J. M., Feb 2026, In: Cancers. 18, 4, 626.Research output: Contribution to journal › Article › peer-review
Open Access -
Assessing the Value of Sequential Next-Generation Sequencing and Multiple Molecular Tumor Board Reviews for Patients With Solid-Tumor Malignancies
Swiecki-Sikora, A. L., Williams, L., Li, N., Yan, D., Bryson, E., Allison, D. B., Miller, R. W., Dietrich, C. S. & Kolesar, J. M., Jan 2026, In: JCO Precision Oncology. 10, e2500272.Research output: Contribution to journal › Article › peer-review
Open Access -
Cancer-associated fibroblast activation protein in Appalachian women with uterine cervix cancer
Fabian, D., Levy, M. S., Piecoro, D. W., Napier, D., Miller, R. W. & Kunos, C. A., 2026, In: Frontiers in Oncology. 16, 1799494.Research output: Contribution to journal › Article › peer-review
Open Access -
Assessing the value of multiple molecular tumor board reviews for sequential next-generation sequencing in patients with solid-tumor malignancies.
Swiecki-Sikora, A., Williams, L., Li, N., Yan, D., Bryson, E., Miller, R. W., Dietrich, C. & Kolesar, J., Jun 2025, In: Journal of Clinical Oncology. 43, p. e23340-e23340Research output: Contribution to journal › Article › peer-review
-
Cisplatin-Containing Combinations Associate with Survival in Women from Appalachian Kentucky with Metastatic, Persistent, or Recurrent Uterine Cervix Cancer
Kunos, C. A., Miller, R. W. & Fabian, D., Oct 2024, In: Cancers. 16, 19, 3319.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations